2318 HK: Top of the range for -17% downside
2318 is a leveraged financial play on the Chinese economy which is not doing very well at the moment. The stock has been consolidation in a range between $68 to $80 from July 2018 to today. Stock is back at the top of the range which suggest there is an asymmetrical risk reward trade set-up.
Technically speaking, it is worthwhile to remember 2318 completed a 3-Drive pattern from the 2009 trough in Jan 2018 while fundamentally speaking, it is a victim of the Chinese deleveraging, slowdown in the private sector and a bombed out stock market. Consolidation channels are generally continuation patterns which suggest 2 potential downside scenario:-
#1 a retest of the channel lower boundary for -17% potential downside target
#2 a breakdown from the channel which would imply a CD leg down to $45 to $48, -40%, which coincides with the 78.6% retracement level of the Feb'16 to Jan'18 up-move.
So far, I am commenting mainly from the technical analysis angle with a smattering of fundamentals/equity story. Do let me know in the comments if you folks prefer more TA, fundamentals or a more nuanced view. Knowledge without timing = 0.
Technically speaking, it is worthwhile to remember 2318 completed a 3-Drive pattern from the 2009 trough in Jan 2018 while fundamentally speaking, it is a victim of the Chinese deleveraging, slowdown in the private sector and a bombed out stock market. Consolidation channels are generally continuation patterns which suggest 2 potential downside scenario:-
#1 a retest of the channel lower boundary for -17% potential downside target
#2 a breakdown from the channel which would imply a CD leg down to $45 to $48, -40%, which coincides with the 78.6% retracement level of the Feb'16 to Jan'18 up-move.
So far, I am commenting mainly from the technical analysis angle with a smattering of fundamentals/equity story. Do let me know in the comments if you folks prefer more TA, fundamentals or a more nuanced view. Knowledge without timing = 0.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.